Analyst Confidence Strong in Annexon (ANNX) Amid Vonaprument Advancement
On November 19, 2025, The Fly reported that Wells Fargo increased its price target on Annexon, Inc. (NASDAQ:ANNX) from $14 to $27, while reiterating an “Overweight” rating.
Annexon Inc. (ANNX)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Biotechnology Value Fund / BVF Inc Mark Lampert | 7,000,000 | $21,350,000 | 0.87% | |
| 2. | Redmile Group Jeremy Green | 6,300,644 | $19,216,964 | 1.87% | |
| 3. | Millennium Management Israel Englander | 2,822,823 | $8,609,610 | +13% | 0% |
| 4. | Woodline Partners Michael Rockefeller And Karl Kroeker | 2,638,275 | $8,046,739 | +151% | 0.04% |
| 5. | Opaleye Management James A. Silverman | 2,600,000 | $7,930,000 | 1.12% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $4.19 | 33,000 | $138,270.00 | 33,000 | 2025-12-01 | Filing | |
| $4.47 | 4,115 | $18,394.05 | 50,290 | 2025-12-01 | Filing | |
| $4.28 | 422,613 | $1,808,783.64 | 9,728,637 | 2025-11-21 | Filing | |
| $4.48 | 400,000 | $1,792,000.00 | 9,306,024 | 2025-11-20 | Filing | |
| $3.94 | 500,000 | $1,970,000.00 | 8,906,024 | 2025-11-19 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $2.58 | 1,116 | $2,879.28 | 105,084 | 2025-07-14 | Filing | |
| $2.58 | 1,117 | $2,881.86 | 121,616 | 2025-07-14 | Filing | |
| $2.61 | 853 | $2,226.33 | 130,689 | 2025-07-14 | Filing | |
| $2.96 | 5,521 | $16,342.16 | 33,479 | 2025-02-18 | Filing | |
| $2.97 | 5,515 | $16,379.55 | 83,814 | 2025-02-18 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 11,081,163 | $33,797,548 | 0% | |
| 2. | 7,899,008 | $24,091,974 | 0% | |
| 3. | 5,835,112 | $17,797,091 | 0% | |
| 4. | 5,249,069 | $16,009,660 | 1.06% | |
| 5. | 5,157,290 | $15,729,735 | 0.33% |
News See All
12 Hot Penny Stocks to Invest in Right Now
Goldman Sachs Asset Management portfolio manager Greg Tuorto appeared on CNBC on November 17, 2025.
Nuveen Expands Portfolio With Annexon, Inc. (ANNX) Acquisition
Annexon, Inc. (NASDAQ:ANNX) is among the best fast money stocks to buy now. During the first quarter, Nuveen LLC acquired a new position in Annexon, Inc.
11 Best Fast Money Stocks to Buy Now
In this fast-paced world, most people have become impatient. Everyone is drawn to whatever delivers quick results, whether it be fast fame or fast money.
10 Best Biotech Penny Stocks to Buy Now
In 2024, the healthcare industry has been doing well, encouraging investors to look into new and exciting opportunities.
10 Buy-Rated Stocks with Latest Insider Purchases
In this article, we will take a detailed look at the 10 Buy-Rated Stocks with Latest Insider Purchases. For a quick overview of such stocks, read our article 5 Buy-Rated Stocks with Latest Insider...
5 Best Biotech Penny Stocks to Buy Now
Ginkgo Bioworks Holdings, Inc. (NYSE:DNA) ranks 5th in our list of the best biotech penny stocks to buy now according to hedge funds. Ginkgo Bioworks Holdings, Inc.
Hedge Fund and Insider Trading News: Bill Ackman, Richard Mashaal, Cheyne Capital Management, Three Arrows Capital, Man Group, Annexon Inc (ANNX), Rocket Companies, Inc. (RKT), and More
Billionaire investor William Ackman, who had raised $4 billion in the biggest-ever special purpose acquisition company (SPAC), told investors he would be returning the sum after failing to find a suitable...
Hedge Fund and Insider Trading News: Toscafund Management, Oaktree Capital Management, Worm Capital, BlackRock, Inc. (BLK), and More
MADRID (Reuters) - Fund manager Reade Griffith bought a minority stake in Spanish broadcaster Mediaset Espana after its parent company MediaForEurope launched a public takeover offer, a filing to the ...
10 Pharmaceutical Stocks to Buy Under $20 According to Jeremy Green's Redmile Group
In this article, we discuss the 10 pharmaceutical stocks to buy under $20 according to Jeremy Green's Redmile Group portfolio based on Q3 holdings of the fund.
Hedge Fund Resource Center Billionaire Hedge Funds
